Literature DB >> 6092094

Induction of human interleukin 1 mRNA measured by collagenase- and prostaglandin E2-stimulating activity in rheumatoid synovial cells.

J M Dayer, C Zavadil-Grob, C Ucla, B Mach.   

Abstract

Human blood peripheral monocyte/macrophages release in culture a mononuclear cell factor (MCF) which stimulates the production of collagenase and prostaglandin E2 by human rheumatoid synovial cells and dermal fibroblasts. These two products play a role in connective tissue destruction. MCF has an apparent molecular weight of approximately 15 000 and is biologically and biochemically indistinguishable from interleukin 1. MCF therefore belongs to the well-documented nonimmune biological activities attributed to interleukin 1. Studies on the mechanisms of production and action of such monokine(s) have been difficult in view of the minute quantities produced by freshly isolated cells or from human monocytic lines. Starting from lectin-stimulated human blood mononuclear cells, we have isolated poly(A)+ RNA and studied its translation following microinjection into Xenopus laevis oocytes. The mRNA translation products stimulated collagenase and prostaglandin E2 production in human rheumatoid synovial cells and dermal fibroblasts. The size of MCF-mRNA was estimated to be 10 S. The mRNA of a member of the interleukin 1 family can now be studied in a system based on a specific and direct relevant biological assay and eventually compared with those of other monokines.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092094     DOI: 10.1002/eji.1830141007

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.

Authors:  P Angel; I Baumann; B Stein; H Delius; H J Rahmsdorf; P Herrlich
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

Review 2.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

3.  Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha.

Authors:  B D Gitter; J M Labus; S L Lees; M E Scheetz
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

4.  Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

Authors:  P A Guerne; B L Zuraw; J H Vaughan; D A Carson; M Lotz
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 5.  Cytokines.

Authors:  H Holtmann; K Resch
Journal:  Naturwissenschaften       Date:  1995-04

6.  The effect of pentoxifylline on the healing of intestinal anastomosis in rats with experimental obstructive jaundice.

Authors:  M Cömert; F Taneri; E Tekin; E Ersoy; S Oktemer; E Onuk; E Düzgün; F Ayoğlu
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

7.  Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).

Authors:  J F Balavoine; B de Rochemonteix; K Williamson; P Seckinger; A Cruchaud; J M Dayer
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

8.  Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.

Authors:  J M Dayer; B de Rochemonteix; B Burrus; S Demczuk; C A Dinarello
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

9.  Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

Authors:  G Buchan; K Barrett; M Turner; D Chantry; R N Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

10.  Some cellular and pathophysiological correlates of the inflammatory effects of a synthetic immunomodulatory agent, muramyl dipeptide (MDP).

Authors:  Z Zídek; D Franková; K Masek
Journal:  Agents Actions       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.